{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T14:14:24Z","timestamp":1778336064208,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004117","name":"A.G. Leventis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004117","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.metabol.2012.01.005","type":"journal-article","created":{"date-parts":[[2012,3,5]],"date-time":"2012-03-05T20:26:21Z","timestamp":1330979181000},"page":"922-930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: A case report and review of the literature"],"prefix":"10.1016","volume":"61","author":[{"given":"Vassos","family":"Neocleous","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicos","family":"Skordis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Shammas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisavet","family":"Efstathiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos P.","family":"Mastroyiannopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonidas A.","family":"Phylactou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2012.01.005_bb0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3949\/ccjm.73.1.65","article-title":"Diabetes insipidus: diagnosis and treatment of a complex disease","volume":"73","author":"Makaryus","year":"2006","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.metabol.2012.01.005_bb0010","doi-asserted-by":"crossref","first-page":"848","DOI":"10.7326\/0003-4819-127-9-199711010-00020","article-title":"Language guiding therapy: the case of dehydration versus volume depletion","volume":"127","author":"Mange","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2012.01.005_bb0015","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM200005183422006","article-title":"Hypernatremia","volume":"342","author":"Adrogue","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2012.01.005_bb0020","first-page":"349","article-title":"Nephrogenic diabetes insipidus","volume":"14","author":"Bichet","year":"1994","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.metabol.2012.01.005_bb0025","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0002-9343(98)00301-5","article-title":"Nephrogenic diabetes insipidus","volume":"105","author":"Bichet","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.metabol.2012.01.005_bb0030","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1542\/pir.21.4.122","article-title":"Diabetes insipidus","volume":"21","author":"Saborio","year":"2000","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.metabol.2012.01.005_bb0035","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1681\/ASN.V1161044","article-title":"Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus","volume":"11","author":"Arthus","year":"2000","journal-title":"J Am Soc Nephrol"},{"issue":"9 Suppl 2","key":"10.1016\/j.metabol.2012.01.005_bb0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0026-0495(90)90199-M","article-title":"Characterization of a cAMP-regulated enhancer-binding protein","volume":"39","author":"Habener","year":"1990","journal-title":"Metabolism"},{"issue":"9 Suppl 2","key":"10.1016\/j.metabol.2012.01.005_bb0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0026-0495(90)90198-L","article-title":"Characteristics of the cAMP response unit","volume":"39","author":"Montminy","year":"1990","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2012.01.005_bb0050","doi-asserted-by":"crossref","first-page":"F257","DOI":"10.1152\/ajprenal.00491.2005","article-title":"Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus","volume":"291","author":"Robben","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.metabol.2012.01.005_bb0055","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0026-0495(98)90302-X","article-title":"Renal water channel expression in newborns: measurement of urinary excretion of aquaporin-2","volume":"47","author":"Tsukahara","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2012.01.005_bb0060","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1043-2760(02)00665-3","article-title":"Aquaporins and disease: lessons from mice to humans","volume":"13","author":"King","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.metabol.2012.01.005_bb0065","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ajmg.1320290138","article-title":"Localization of the gene for X-linked nephrogenic diabetes insipidus to Xq28","volume":"29","author":"Kambouris","year":"1988","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.metabol.2012.01.005_bb0070","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/359233a0","article-title":"Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus","volume":"359","author":"Rosenthal","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2012.01.005_bb0075","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/357333a0","article-title":"Molecular cloning of the receptor for human antidiuretic hormone","volume":"357","author":"Birnbaumer","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2012.01.005_bb0080","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/357336a0","article-title":"Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus","volume":"357","author":"Lolait","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2012.01.005_bb0085","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/jcp.21552","article-title":"AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance","volume":"217","author":"Spanakis","year":"2008","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.metabol.2012.01.005_bb0090","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1210\/mend.11.12.0017","article-title":"Biochemical basis of partial nephrogenic diabetes insipidus phenotypes","volume":"11","author":"Sadeghi","year":"1997","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.metabol.2012.01.005_bb0095","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1681\/ASN.V9101861","article-title":"Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype","volume":"9","author":"Ala","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2012.01.005_bb0100","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1681\/ASN.V8121855","article-title":"Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus","volume":"8","author":"Vargas-Poussou","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2012.01.005_bb0105","first-page":"1703","article-title":"Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families","volume":"85","author":"Pasel","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2012.01.005_bb0110","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1210\/jcem.86.1.7165","article-title":"The property of a novel v2 receptor mutant in a patient with nephrogenic diabetes insipidus","volume":"86","author":"Inaba","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2012.01.005_bb0115","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s100380200002","article-title":"Identification of mutations in the arginine vasopressin receptor 2 gene causing nephrogenic diabetes insipidus in Chinese patients","volume":"47","author":"Chen","year":"2002","journal-title":"J Hum Genet"},{"key":"10.1016\/j.metabol.2012.01.005_bb0120","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2265.2007.03054.x","article-title":"Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene","volume":"68","author":"Faerch","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.metabol.2012.01.005_bb0125","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000308167","article-title":"Functional characterization of vasopressin receptor 2 mutations causing partial and complete congenital nephrogenic diabetes insipidus in Thai families","volume":"73","author":"Sahakitrungruang","year":"2010","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.metabol.2012.01.005_bb0130","doi-asserted-by":"crossref","first-page":"F1518","DOI":"10.1152\/ajprenal.00331.2009","article-title":"Diverse vasopressin V2 receptor functionality underlying partial congenital nephrogenic diabetes insipidus","volume":"297","author":"Faerch","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.metabol.2012.01.005_bb0135","first-page":"278","article-title":"Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus","volume":"55","author":"Bichet","year":"1994","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.metabol.2012.01.005_bb0140","doi-asserted-by":"crossref","first-page":"F265","DOI":"10.1152\/ajprenal.00404.2004","article-title":"Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model","volume":"289","author":"Robben","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.metabol.2012.01.005_bb0145","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1046\/j.1523-1755.1998.00214.x","article-title":"AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus","volume":"54","author":"Wildin","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.metabol.2012.01.005_bb0150","doi-asserted-by":"crossref","first-page":"p1","DOI":"10.1159\/000245059","article-title":"Vasopressin type 2 receptor V88M mutation: molecular basis of partial and complete nephrogenic diabetes insipidus","volume":"114","author":"Bockenhauer","year":"2009","journal-title":"Nephron Physiol"},{"key":"10.1016\/j.metabol.2012.01.005_bb0155","doi-asserted-by":"crossref","first-page":"186","DOI":"10.7326\/0003-4819-144-3-200602070-00007","article-title":"Nephrogenic diabetes insipidus","volume":"144","author":"Sands","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2012.01.005_bb0160","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1074\/jbc.M111.268797","article-title":"V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlights protean agonism of V2R antagonists","volume":"287","author":"Takahashi","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2012.01.005_bb0165","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1681\/ASN.2005040371","article-title":"Molecular biology of hereditary diabetes insipidus","volume":"16","author":"Fujiwara","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2012.01.005_bb0170","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1172\/JCI118252","article-title":"Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus","volume":"96","author":"Tsukaguchi","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2012.01.005_bb0175","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/(SICI)1096-8628(19960102)61:1<81::AID-AJMG17>3.0.CO;2-S","article-title":"Cognitive and psychosocial functioning of patients with congenital nephrogenic diabetes insipidus","volume":"61","author":"Hoekstra","year":"1996","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.metabol.2012.01.005_bb0180","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/jmg.2007.055210","article-title":"Human gene mutation database: towards a comprehensive central mutation database","volume":"45","author":"Stenson","year":"2008","journal-title":"J Med Genet"},{"key":"10.1016\/j.metabol.2012.01.005_bb0185","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrendo.2011.100","article-title":"Familial forms of diabetes insipidus: clinical and molecular characteristics","volume":"7","author":"Babey","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2012.01.005_bb0190","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2265.2008.03513.x","article-title":"Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus","volume":"71","author":"Ranadive","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.metabol.2012.01.005_bb0195","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1681\/ASN.V122207","article-title":"Increased abundance of distal sodium transporters in rat kidney during vasopressin escape","volume":"12","author":"Ecelbarger","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2012.01.005_bb0200","doi-asserted-by":"crossref","first-page":"F46","DOI":"10.1152\/ajprenal.2000.279.1.F46","article-title":"Vasopressin-mediated regulation of epithelial sodium channel abundance in rat kidney","volume":"279","author":"Ecelbarger","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.metabol.2012.01.005_bb0205","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods"},{"key":"10.1016\/j.metabol.2012.01.005_bb0210","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/(SICI)1098-1004(1998)12:2<137::AID-HUMU16>3.0.CO;2-J","article-title":"C112R, W323S, N317K mutations in the vasopressin V2 receptor gene in patients with nephrogenic diabetes insipidus. Mutations in brief no. 165. Online","volume":"12","author":"Szalai","year":"1998","journal-title":"Hum Mutat"},{"key":"10.1016\/j.metabol.2012.01.005_bb0215","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1093\/emboj\/18.9.2394","article-title":"An impaired routing of wild-type aquaporin-2 after tetramerization with an aquaporin-2 mutant explains dominant nephrogenic diabetes insipidus","volume":"18","author":"Kamsteeg","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.metabol.2012.01.005_bb0220","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/10466","article-title":"Integration of endoplasmic reticulum signaling in health and disease","volume":"5","author":"Aridor","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2012.01.005_bb0225","first-page":"63607","article-title":"Nephrogenic diabetes insipidus","author":"Morello","year":"2001","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.metabol.2012.01.005_bb0230","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1172\/JCI116698","article-title":"X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis","volume":"92","author":"Bichet","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2012.01.005_bb0235","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.ackd.2006.01.006","article-title":"Nephrogenic diabetes insipidus","volume":"13","author":"Bichet","year":"2006","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.metabol.2012.01.005_bb0240","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1681\/ASN.V1091958","article-title":"Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus","volume":"10","author":"van Lieburg","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2012.01.005_bb0245","doi-asserted-by":"crossref","first-page":"13030","DOI":"10.1016\/S0021-9258(19)38614-4","article-title":"Nephrogenic diabetes insipidus. A V2 vasopressin receptor unable to stimulate adenylyl cyclase","volume":"268","author":"Rosenthal","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2012.01.005_bb0250","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1507\/endocrj.K07-083","article-title":"Correlation between clinical phenotypes and X-inactivation patterns in six female carriers with heterozygote vasopressin type 2 receptor gene mutations","volume":"55","author":"Satoh","year":"2008","journal-title":"Endocr J"},{"key":"10.1016\/j.metabol.2012.01.005_bb0255","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/gm13","article-title":"The human gene mutation database: 2008 update","volume":"1","author":"Stenson","year":"2009","journal-title":"Genome Med"},{"key":"10.1016\/j.metabol.2012.01.005_bb0260","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ki.1994.256","article-title":"Inheritance of mutations in the V2 receptor gene in thirteen families with nephrogenic diabetes insipidus","volume":"46","author":"Knoers","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.metabol.2012.01.005_bb0265","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1681\/ASN.V1161033","article-title":"Nephrogenic diabetes insipidus: functional analysis of new AVPR2 mutations identified in Italian families","volume":"11","author":"Albertazzi","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2012.01.005_bb0270","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1507\/endocrj.50.809","volume":"50","author":"Miyakoshi","year":"2003","journal-title":"Endocr J"},{"key":"10.1016\/j.metabol.2012.01.005_bb0275","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1124\/mol.109.061804","article-title":"Functional characterization of vasopressin type 2 receptor substitutions (R137H\/C\/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: implications for treatments","volume":"77","author":"Rochdi","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.metabol.2012.01.005_bb0280","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/00063030-200721030-00003","article-title":"Pharmacological chaperones in nephrogenic diabetes insipidus: possibilities for clinical application","volume":"21","author":"Robben","year":"2007","journal-title":"BioDrugs"},{"key":"10.1016\/j.metabol.2012.01.005_bb0285","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1172\/JCI8688","article-title":"Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants","volume":"105","author":"Morello","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2012.01.005_bb0290","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1681\/ASN.2005080854","article-title":"Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus","volume":"17","author":"Bernier","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2012.01.005_bb0295","doi-asserted-by":"crossref","first-page":"F253","DOI":"10.1152\/ajprenal.00247.2006","article-title":"Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus","volume":"292","author":"Robben","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.metabol.2012.01.005_bb0300","doi-asserted-by":"crossref","first-page":"12195","DOI":"10.1073\/pnas.0900130106","article-title":"Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by nonpeptide agonists","volume":"106","author":"Robben","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.metabol.2012.01.005_bb0305","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.semnephrol.2008.03.010","article-title":"Bypassing vasopressin receptor signaling pathways in nephrogenic diabetes insipidus","volume":"28","author":"Bouley","year":"2008","journal-title":"Semin Nephrol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049512000339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049512000339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:55:42Z","timestamp":1758426942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049512000339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":61,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0026049512000339"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2012.01.005","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: A case report and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2012.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}